GSK-5959 |
Antagonist of BRPF1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| BRPF1 |
|
|
Antagonist
between 500 nM and 5 uM
Selectivity
In Vitro Selectivity Assessment
Potency: pIC50 - BRPF2: 5.1, BRPF3 <4, BRD4 (1) <4.3, BRD4 (2) <4.3
Potency Assay Off-Target:
TR-FRET binding assay
Selectivity Assessment Description:
In BROMOscan with 35 bromodomains (DiscoveRx), GSK-5959 was selective for BRPF1.
In Cell Selectivity Assessment
Potency Assay Off-Target:
In nanoBRET assay, GSK-5959 is not active against BRPF1 isoform 2.
Potency Cellular
In Vitro
BRPF1
Mode of Action: Antagonist
Structure-Activity-Relationship data available? No
Orthogonal Probes def
NI-57
Chemical Information
| Molecular Formula | C22H26N4O3 |
| SMILEs | COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCCC1)n(C)c(=O)n2C |
| InChI | InChI=1S/C22H26N4O3/c1-24-18-13-16(23-21(27)15-9-5-6-10-20(15)29-3)17(26-11-7-4-8-12-26)14-19(18)25(2)22(24)28/h5-6,9-10,13-14H,4,7-8,11-12H2,1-3H3,(H,23,27) |
| Molecular weight | 394.20 Da |
| AlogP | 3.1282000000000014 |
| HBond acceptors | 7 |
| HBond donors | 1 |
| Atoms | 55 |
References
Publications
Cross References
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.